期刊文献+

p73基因rs6695978位点基因型与卵巢癌病理特征和预后的相关性分析

The correlation analysis of rs6695978 locus genotype of p73 gene with pathological features and prognosis of ovarian cancer patients
下载PDF
导出
摘要 目的观察p73基因rs6695978位点基因型在卵巢癌患者中的分布情况,探讨p73基因rs6695978位点基因型与卵巢癌病理特征和预后的相关性,为临床诊断和治疗提供参考。方法选取2017年10月至2021年5月该院收治的76例卵巢癌患者作为研究对象,所有患者均接受基因测序,检测p73基因rs6695978位点的基因型分布情况。比较不同基因型患者临床特征指标和预后,分析影响卵巢癌患者p73基因rs6695978位点基因型的相关因素。结果p73基因rs6695978位点不同基因型患者肿瘤最大径、肿瘤分期、分化程度比较,差异均有统计学意义(P<0.05)。多元逐步回归分析结果显示,肿瘤分期、分化程度与p73基因rs6696978位点基因型分布密切相关(P<0.05)。GG基因型患者32例,中位随访时间27.56个月,死亡10例,存活22例,生存率为68.75%,GA+AA基因型患者44例,中位随访时间28.01个月,死亡24例,存活20例,生存率为45.45%,不同基因型患者生存率比较,差异有统计学意义(P<0.05)。结论p73基因rs6695978位点基因型分布与卵巢癌患者病理特征和预后相关,携带A等位基因的卵巢癌患者预后更差。 Objective To observe the distribution of rs6695978 locus genotype of p73 gene in ovarian cancer patients,and investigate the correlation between rs6695978 locus genotype of p73 gene and pathological features and prognosis of ovarian cancer to provide reference for clinical diagnosis and treatment.Methods A total of 76 patients with ovarian cancer admitted to Northwest Women is and Children′s Hospital from October 2017 to May 2021 were selected as the research subjects.All patients received gene sequencing.The genotype distribution of rs6695978 locus of p73 gene was detected.The clinical characteristics and prognosis of patients with different genotype were compared.The related factors,which affected the genotype of rs6695978 locus of p73 gene were analyzed.Results There were statistically significant differences in tumor diameter,tumor stage and differentiation degree among patients with different genotype at rs6695978 locus of p73 gene(P<0.05).The multiple step regression analysis showed that the tumor stage and differentiation were closely related to genotype distribution of rs6696978 locus of p73 gene(P<0.05).There were 32 patients with GG genotype.The median follow-up time was 27.56 months.Ten patients died and 22 survived,the survival rate was 68.75%.There were 44 patients with GA+AA genotype,and the median follow-up time was 28.01 months.Totally 24 patients died and 20 patients survived,the survival rate was 45.45%.The survival rate of patients with different genotype was significantly different(P<0.05).Conclusion The genotype distribution of rs6695978 locus of p73 gene is correlated with the pathological features and prognosis of ovarian cancer patients,and the prognosis of ovarian cancer patients carrying A allele is worse.
作者 袁淼 苏琦 刘竹君 YUAN Miao;SU Qi;LIU Zhujun(Department of Three Branches of Gynecology,Northwest Women′s and Children′s Hospital,Xi′an,Shaanxi 710061,China;Department of Pharmacy,Northwest Women′s and Children′s Hospital,Xi′an,Shaanxi 710061,China)
出处 《检验医学与临床》 CAS 2023年第2期207-209,214,共4页 Laboratory Medicine and Clinic
关键词 卵巢癌 P73基因 病理特征 预后 ovarian cancer p73 gene pathological features prognosis
  • 相关文献

参考文献10

二级参考文献32

  • 1李巍,崔恒,冯捷,李艺.卵巢癌诊断的研究进展[J].中华妇产科杂志,2005,40(7):496-498. 被引量:74
  • 2Yu S,Cai X,Wu C,Wu L,et al.Adhesion glycoprotein CD44functions as an upstream regulator of a network connecting ERK,AKT and Hippo-YAP pathways in cancer progression[J].Oncotarget,2015,6(5):2951-2965.
  • 3Orzol P,Holcakova J,Nekulova M,et al.The diverse oncogenic and tumour suppressor roles of p63 and p73 in cancer:a review by cancersite[J].Histol Histopathol,2015,30(5):503-521.
  • 4Sudol M.Yes-associated protein(YAP65)is a proline-rich phosphoprotein that binds to the SH3 domain of the Yes proto-oncogene product[J].Oncogene,1994,9(8):2145-2152.
  • 5Salah Z,Itzhaki E,Aqeilan RI.The ubiquitin E3 ligase ITCH enhances breast tumor progression by inhibiting the Hippo tumor suppressor pathway[J].Oncotarget,2014,5(21):10886-10900.
  • 6Jiao S,Wang H,Shi Z,et al.A peptide mimicking VGLL4 function acts as a YAP antagonist therapy against gastric cancer[J].Cancer Cell,2014,25(2):166-180.
  • 7Xia Y,Chang T,Wang Y,et al.YAP promotes ovarian cancer cell tumorigenesis and is indicative of a poor prognosis for ovarian cancer patients[J].PLo S One,2014,9(3):e91770.
  • 8Hall CA,Wang R,Miao J,et al.Hippo pathway effector Yap is an ovarian cancer oncogene[J].Cancer Res,2010,70(21):8517-8525.
  • 9Xia Y,Zhang YL,Yu C,et al.YAP/TEAD Co-Activator Regulated Pluripotency and Chemoresistancein Ovarian Cancer Initiated Cells[J].PLo S One,2014,9(11):e109575.
  • 10Liao J,Wen S,Cao L,et al.Effect of Eradication of Helicobacter pylori on Expression Levels of FHIT,IL-8 and P73 in Gastric Mucosa of First-Degree Relatives of Gastric Cancer Patients[J].PLo S One,2015,10(4):e0124576.

共引文献112

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部